TipRanks
Go Ultimate55% OFF

CareTrust REIT (7XC) AI Stock Analysis

DE:7XC

CareTrust REIT

(Frankfurt:7XC)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Raised earnings guidanceRaised full-year guidance and double-digit projected growth indicate strong operating momentum and management confidence in the portfolio. If delivered, higher recurring FFO and FAD should support internally funded growth, dividend capacity, and stronger earnings power over the next several quarters.
Negative Factors
SHOP competitionGreater competition in the SHOP market can reduce acquisition yields and make growth opportunities less attractive on a risk-adjusted basis. Persistent pricing pressure may limit CareTrust’s ability to deploy capital accretively, requiring stricter underwriting or a slower expansion pace in this segment.

CareTrust REIT (7XC) vs. iShares MSCI Germany ETF (EWG)

-10%-5%0%5%10%15%20%25%30%DE:7XC+9.54%EWG+4.43%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
EUR 8.60B
Dividend Yield
4.11%
Average Volume (3M)
77
Price to Earnings (P/E)
22.6
Beta (1Y)
0.24
Revenue Growth
42.91%
EPS Growth
23.48%
Country
Germany
Employees
43
Sector
Real Estate
Sector Strength
65
Industry
REIT - Healthcare Facilities

CareTrust REIT Business Overview & Revenue Model

Company Description

CareTrust REIT, Inc. operates as a self-managed, publicly traded real estate investment trust. The company specializes in the ownership, acquisition, development, and leasing of various healthcare properties, including skilled nursing facilities, sen...

CareTrust REIT Earnings Call Summary

Earnings Call Date:Aug 05, 2026(Q2-2026)|% Change Since:-8.59%|Next Earnings Date:Nov 04, 2026
Earnings Call SentimentPositive

The call was strongly positive on operational and financial performance: record quarterly investments, robust YTD deployment (~$1.5B), double-digit per-share growth guidance, materially higher normalized FFO/FAD and conservative leverage with ample liquidity. Offsetting items are focused and tactical: competitive pressures and cap rate compression in the SHOP market, modest pricing premium on a large U.K. buy, reliance on unsettled equity forward proceeds and certain guidance assumptions, and multi-year uncertainty around financing receivable purchase options. Overall the strengths (record investment activity, significant FFO/FAD growth, strong balance sheet and operator quality) materially outweigh the select execution and market risks discussed.

Positive Updates

Record Quarterly and Year-to-Date Investments
Closed approximately $900 million of investments in Q2 at a blended stabilized yield of 8.9% (single largest investment quarter excluding M&A). Since June 30, an additional ~$308 million closed at ~7.8% yield. Year-to-date investments total approximately $1.5 billion.

Negative Updates

SHOP: Competitive Pressure and Cap Rate Compression
Increased private-market entrant activity and competition in the SHOP space has compressed cap rates and made it difficult to secure attractive risk-adjusted returns. Management noted missing some SHOP deals primarily on price and that SHOP transactions have become more competitive.

Company Guidance

CareTrust raised full-year 2026 guidance, now projecting normalized FFO per share of $2.03–$2.06 and normalized FAD per share of $2.01–$2.04 (midpoint implying ~16.2% FFO/share and ~15.1% FAD/share growth vs. 2025) based on a weighted average diluted share count of 233 million; the outlook assumes no new investments/loans/dispositions or debt/equity issuances beyond year‑to‑date activity, 2.5% inflation-based rent escalators on long‑term triple‑net leases, $147 million of loans to be repaid during the year (≈$104 million received to date), and no material change in GBP/USD. The company noted ample liquidity to fund guidance with roughly $1.4 billion available (≈$90 million cash, $605 million revolver availability on a $1.2 billion facility, ≈$671 million unsettled equity forwards and ≈$785.8 million ATM capacity), a net debt to annualized normalized run‑rate EBITDA of 1.0x, fixed charge coverage of 9.9x, and no scheduled debt maturities before 2028.

CareTrust REIT Risk Analysis

CareTrust REIT disclosed 50 risk factors in its most recent earnings report. CareTrust REIT reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

1 New Risk
1..We have disclosed under the heading “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2025 risk factors which materially affect our business, financial condition, or results of operations. There have been no material changes from the risk factors previously disclosed, except as noted below.Our use of, or inability to use, artificial intelligence (“AI”) presents risks and challenges that may adversely impact our business and operating results or the business and operating results of our tenants, managers, borrowers or business partners.We use, and may expand our use of, generative artificial intelligence and machine learning (collectively, “AI”). If our peers use AI tools to optimize operations and we fail to utilize AI tools in a comparable manner, we may be competitively disadvantaged. While AI tools may facilitate optimization and operational efficiencies, they also have the potential for inaccuracy, bias, infringement or misappropriation of intellectual property. The use of AI tools may introduce errors or inadequacies that are not easily detectable, including deficiencies, inaccuracies, or biases in the data used for AI training, or in the content, analyses, or recommendations generated by AI applications. Uncertainty around the safety and security of new and emerging AI applications may require additional investment in the development of proprietary datasets, machine learning models and systems to test for security, accuracy, bias and other variables, which are often complex, may be costly and could impact our operating results. Cybersecurity threat actors may also utilize AI tools to automate and enhance cybersecurity attacks against us and could lead to data breaches, loss of confidential or sensitive information, and financial or reputational harm. Additionally, AI-enabled solutions and features may become more important to our tenants, managers, borrowers and business partners over time. They may also incorporate AI into their products and services without disclosing such use to us or fail to disclose risks presented by their use of AI. If our tenants, managers, borrowers or business partners use AI tools that do not meet existing or rapidly evolving regulatory or industry standards with respect to privacy and data protection, compliance and transparency, among others, it could inhibit our and their ability to maintain an adequate level of functionality or service. Our use of third-party AI models, platforms, vendors, datasets, or infrastructure relies on safeguards implemented by those third parties, including safeguards related to model performance, availability, privacy, data use, security, intellectual property, confidentiality, accuracy, bias mitigation, regulatory compliance, and other matters, and these safeguards may be insufficient. Third-party AI providers may also change their models, terms, pricing, availability, data-use practices, privacy and security commitments, intellectual property positions, or compliance posture in ways that adversely affect our operations, costs, or ability to meet our contractual or regulatory obligations. Interruptions, errors, degradation, security incidents, or changes involving third-party AI technologies could impair our products or internal operations and could adversely affect our business.Additionally, the complex and rapidly evolving landscape around AI may expose us to claims, inquiries, demands and proceedings by private parties and global regulatory authorities and subject us to legal liability as well as reputational harm. New laws and regulations are being adopted in the U.S. and in non-U.S. jurisdictions, and existing laws and regulations may be interpreted in ways that would affect our business operations and the way in which we use AI. Future regulations could impose restrictions on the use of AI technology and require us to incur significant costs to implement compliance measures or change the way in which we use AI. Any of these outcomes could impair our ability to compete effectively, damage our reputation, result in the loss of valuable property or information and adversely impact our results of operations.In addition, investors, analysts, and other market participants may use AI tools to process, summarize or interpret our financial information or other data about us. The use of AI tools in financial and market analysis may introduce risks similar to those described above, including an inaccurate interpretation of our financial or operational performance or market trends or conditions, which in turn could result in inaccurate conclusions or investment recommendations.48Q2, 2026

CareTrust REIT Peers Comparison

Overall Rating

UnderperformOutperform
Sector (65)

Financial Indicators

DE:7XC against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
LTCLTC80Outperform$2.41B15.8712.28%5.09%59.94%49.34%
OHIOHI80Outperform$14.24B16.2616.51%5.73%15.18%72.69%
NHINHI68Neutral$3.29B19.3210.96%5.52%23.77%10.04%
Sector *65Neutral$2.17B12.193.79%4.94%3.15%1.96%
SBRASBRA65Neutral$5.04B74.772.34%6.08%18.43%-65.50%
STRWSTRW65Neutral$710.14M19.8372.36%5.20%18.27%6.18%

* Real Estate Sector Average

Performance Comparison

-10%0%10%20%30%DE:7XCLTCNHIOHISBRASTRWDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
DE:7XC and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:7XCCareTrust REIT32.203.0010.26%
LTCLtc Properties44.7511.4034.17%
NHINational Health Investors67.04-4.09-5.74%
OHIOmega Healthcare Investors46.986.7616.80%
SBRASabra Healthcare Reit19.742.9017.21%
STRWStrawberry Fields REIT Inc12.691.7015.42%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.